Deep learning for image analysis: Personalizing medicine closer to the point of care
- 2 January 2019
- journal article
- review article
- Published by Taylor & Francis in Critical Reviews in Clinical Laboratory Sciences
- Vol. 56 (1) , 61-73
Abstract
The precision-based revolution in medicine continues to demand stratification of patients into smaller and more personalized subgroups. While genomic technologies have largely led this movement, diagnostic results can take days to weeks to generate. Management at, or closer to, the point of care still heavily relies on the subjective qualitative interpretation of clinical and diagnostic imaging findings. New and emerging technological advances in artificial intelligence (AI) now appear poised to help bring objectivity and precision to these traditionally qualitative analytic tools. In particular, one specific form of AI, known as deep learning, is achieving expert-level disease classifications in many areas of diagnostic medicine dependent on visual and image-based findings. Here, we briefly review concepts of deep learning, and more specifically recent developments in convolutional neural networks (CNNs), to highlight their transformative potential in personalized medicine and, in particular, diagnostic histopathology. Understanding the opportunities and challenges of these quantitative machine-based decision support tools is critical to their widespread introduction into routine diagnostics.Keywords
Funding Information
- Brain Tumour Foundation of Canada
This publication has 37 references indexed in Scilit:
- Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosisScientific Reports, 2016
- Automated classification of brain tumor type in whole-slide digital pathology images using local representative tilesMedical Image Analysis, 2016
- Representation learning for mammography mass lesion classification with convolutional neural networksComputer Methods and Programs in Biomedicine, 2016
- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse GliomaCell, 2016
- Integrated genomic characterization of IDH1-mutant glioma malignant progressionNature Genetics, 2015
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade GliomasNew England Journal of Medicine, 2015
- Deep learningNature, 2015
- Mass-spectrometry-based draft of the human proteomeNature, 2014
- Right Drug—Right Patient—Right Time: Personalized Medicine CoalitionClinical and Translational Science, 2008
- Skin cancer control in the primary care settingJournal of General Internal Medicine, 2001